by Stacey Johnson | Mar 4, 2016
Last week, I wrote about Dr. Leon Bellan’s creative solution to engineering artificial blood vessels for lab-grown organs: cotton candy! As much as I was impressed with his out-of-the-box thinking, I also really liked the excellent video produced by Vanderbilt...
by Nicole Kuchinsky | Feb 29, 2016
Japan is making bold moves to redefine how cell therapies make it to market, and the world is taking notice. In late January, the Japan External Trade Organization (JETRO) collaborated with the Centre for Commercialization of Regenerative Medicine (CCRM) to host a...
by Stacey Johnson | Feb 26, 2016
Whether you call it cotton candy, candy floss or the original name for it “fairy floss,” I’m going to assume you’ve never called it “a tool for creating artificial blood vessels.” (Too long and not very appetizing.) Nevertheless, Dr. Leon Bellan, Vanderbilt...
by Mark Curtis | Feb 18, 2016
Welcome to your Cell Therapy Deal Review for the month of January. Things got off to a quick start with a number of cell-based immunotherapy companies announcing deals and research collaborations out of the gate, including a third acquisition by Juno. Juno...
by Nicole Kuchinsky | Feb 17, 2016
Cell therapy is not a new idea. Bone marrow transplantation—the first ever cell therapy—has been around since the 1950s. Over half a century of research has brought important advancements, yet this technology has struggled to make it to prime time. Understandably,...
Comments